Cleared Traditional

K163644 - Nihon Kohden QP-160AK EEG Trend Program (FDA 510(k) Clearance)

May 2017
Decision
147d
Days
Class 2
Risk

K163644 is an FDA 510(k) clearance for the Nihon Kohden QP-160AK EEG Trend Program. This device is classified as a Amplitude-integrated Electroencephalograph (Class II - Special Controls, product code OMA).

Submitted by Nihon Kohden Corporation (Tokyo, JP). The FDA issued a Cleared decision on May 19, 2017, 147 days after receiving the submission on December 23, 2016.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Measure And Record Electrical Activity Of The Brain By Acquisition Of Amplitude-integrated Electroencephalograph (electroencephalograph Signals That Have Been Filtered And Displayed In A Specific Manner)..

Submission Details

510(k) Number K163644 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 2016
Decision Date May 19, 2017
Days to Decision 147 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code OMA - Amplitude-integrated Electroencephalograph
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Measure And Record Electrical Activity Of The Brain By Acquisition Of Amplitude-integrated Electroencephalograph (electroencephalograph Signals That Have Been Filtered And Displayed In A Specific Manner).